Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Yizhak Kupfer is active.

Publication


Featured researches published by Yizhak Kupfer.


BMJ | 2004

Corticosteroids for severe sepsis and septic shock: a systematic review and meta-analysis

Djillali Annane; Eric Bellissant; Pierre Edouard Bollaert; Josef Briegel; Didier Keh; Yizhak Kupfer

Abstract Objective To assess the effects of corticosteroids on mortality in patients with severe sepsis and septic shock. Data sources Randomised and quasi-randomised trials of corticosteroids versus placebo (or supportive treatment alone) retrieved from the Cochrane infectious diseases groups trials register, the Cochrane central register of controlled trials, Medline, Embase, and LILACS. Review method Two pairs of reviewers agreed on eligibility of trials. One reviewer entered data on to the computer and four reviewers checked them. We obtained some missing data from authors of trials and assessed methodological quality of trials. Results 16/23 trials (n = 2063) were selected. Corticosteroids did not change 28 day mortality (15 trials, n = 2022; relative risk 0.92, 95% confidence interval 0.75 to 1.14) or hospital mortality (13 trials, n = 1418; 0.89, 0.71 to 1.11). There was significant heterogeneity. Subgroup analysis on long courses (≥ 5 days) with low dose (≤ 300 mg hydrocortisone or equivalent) corticosteroids showed no more heterogeneity. The relative risk for mortality was 0.80 at 28 days (five trials, n = 465; 0.67 to 0.95) and 0.83 at hospital discharge (five trials, n = 465, 0.71 to 0.97). Use of corticosteroids reduced mortality in intensive care units (four trials, n = 425, 0.83, 0.70 to 0.97), increased shock reversal at 7 days (four trials, n = 425; 1.60, 1.27 to 2.03) and 28 days (four trials, n = 425, 1.26, 1.04 to 1.52) without inducing side effects. Conclusions For all trials, regardless of duration of treatment and dose, use of corticosteroids did not significantly affect mortality. With long courses of low doses of corticosteroids, however, mortality at 28 days and hospital morality was reduced.


Annals of Internal Medicine | 1992

Prolonged Weakness after Long-Term Infusion of Vecuronium Bromide

Yizhak Kupfer; Tatsuji Namba; Emad Kaldawi; Sidney Tessler

Excerpt Vecuronium bromide is a nondepolarizing neuromuscular blocking agent chemically similar to pancuronium, but with minimal cardiovascular side effects (1). Unlike other neuromuscular blocking...


Scandinavian Journal of Infectious Diseases | 2011

Systemic absorption of oral vancomycin in patients with Clostridium difficile infection

Sriharsha Rao; Yizhak Kupfer; Murali Pagala; Edward K. Chapnick; Sidney Tessler

Abstract Oral vancomycin is utilized in the treatment of severe Clostridium difficile infection (CDI). We prospectively measured serum vancomycin concentrations (SVC) in patients treated with oral vancomycin. The SVC was measured by immunoassay prior to, and at least 3 days after, the administration of oral vancomycin 125 mg every 6 h. Patients treated with intravenous vancomycin were excluded. Fifty-seven patients with a mean age of 74 y (± 18) were enrolled. There was no detectable SVC in 56 patients (98%); 1 patient had a transient SVC of 6.7 μg/ml that was not detectable on subsequent testing. The severity of the CDI and/or renal failure did not have an effect on SVC. Orally administered vancomycin at 125 mg 4 times daily was not absorbed from the gastrointestinal tract.


Gastroenterology Clinics of North America | 2000

ACUTE GASTROINTESTINAL BLEEDING IN THE INTENSIVE CARE UNIT: The Intensivist's Perspective

Yizhak Kupfer; Mitchell S. Cappell; Sidney Tessler

Gastrointestinal (GI) hemorrhage is a common and potentially lethal medical emergency that is a common cause for intensive care unit admission. The intensivist plays an important role as a member of the medical team managing the patient with GI bleeding who is at high risk because of severe bleeding, comorbidity, or the presence of endoscopic stigmata of recent hemorrhage. This article presents the intensivists approach to GI hemorrhage in initial patient assessment, triage, resuscitation, specialist consultation, diagnostic evaluation, and medical therapy. This article focuses on types of GI bleeding of particular concern to the intensivist, including esophageal variceal bleeding, stress-related GI bleeding, and GI bleeding associated with myocardial infarcation.


Scandinavian Journal of Infectious Diseases | 2014

Epidemiology and outcome of infections with carbapenem-resistant Gram-negative bacteria treated with polymyxin B-based combination therapy

Robbert Crusio; Sriharsha Rao; Nisarg Changawala; Vishesh Paul; Ceres T. Tiu; Joost R. van Ginkel; Edward K. Chapnick; Yizhak Kupfer

Abstract Introduction: Infections with carbapenem-resistant Gram-negative bacteria (CRGNB) are increasing and are associated with a high mortality. Synergistic effects of combination therapy with a polymyxin, carbapenem, and rifampin have been observed in in vitro studies. Clinical data are limited to retrospective studies. Methods: We performed an observational cohort study of patients over 18 y of age who were treated with polymyxin B combination therapy. Results: One hundred and four patients were studied. The mean age was 77 y; 73% had recently received antibiotics, 67% had recently been hospitalized, and 47% lived in a nursing facility. The most common infections were pneumonia and urinary tract infection due to Acinetobacter baumannii (33%), Klebsiella pneumoniae (24%), and Pseudomonas aeruginosa (11%). Treatment regimens included polymyxin B with a carbapenem in 48%, with additional rifampin in 23%. Clinical success was achieved in 50% and reinfection occurred in 25%. Treatment-related acute renal failure occurred in 14.4%. No treatment-related hemodialysis was needed. All-cause hospital mortality was 47% and mortality after 6 months was 77%. No significant difference was found between treatment regimens. Age (odds ratio (OR) 10.4 per 10 y, p = 0.04), severity of acute illness (OR 2.2 per point, p < 0.001), and Charlson score (OR 1.12 per point, p = 0.04) were associated with hospital mortality. K. pneumoniae was associated with increased hospital survival compared to other CRGNB (p = 0.03). Conclusion: CRGNB infections are associated with previous antibiotic and health care exposure. Mortality is related to age and the severity of chronic and acute illness.


Chest | 2011

Chest Tube Drainage of Transudative Pleural Effusions Hastens Liberation From Mechanical Ventilation

Yizhak Kupfer; Chanaka Seneviratne; Kabu Chawla; Sidney Tessler

BACKGROUND Pleural effusions occur frequently in patients requiring mechanical ventilatory support. Treatment of the precipitating cause and resolution of the pleural effusion may take considerable time. We retrospectively studied the effect of chest tube drainage of transudative pleural effusions on the liberation of patients from mechanical ventilatory support. METHODS Patients in the medical ICU (MICU) at Maimonides Medical Center between January 1, 2009, and October 31, 2009, requiring mechanical ventilatory support with a transudative pleural effusion, were studied retrospectively. They were divided into two groups: standard care and standard care plus chest tube drainage. Chest tubes were placed under ultrasound guidance by trained intensivists. Duration of mechanical ventilatory support was the primary end point. Secondary end points included measures of oxygenation, amount of fluid drained, and complications associated with the chest tube. RESULTS A total of 168 patients were studied; 88 were treated with standard care and 80 underwent chest tube drainage. Total duration of mechanical ventilatory support was significantly shorter for patients who had chest tube drainage: 3.8±0.5 days vs 6.5±1.1 days for the standard group (P=.03). No differences in oxygenation were noted between the two groups. The average amount of fluid drained was 1,220 mL. No significant complications were caused by chest tube drainage. CONCLUSIONS Chest tube drainage of transudative pleural effusions resulted in more rapid liberation from mechanical ventilatory support. It is a very safe procedure when performed under ultrasound guidance by experienced personnel. TRIAL REGISTRY ClinicalTrials.gov; Identifier: NCT0114285; URL: www.clinicaltrials.gov.


Case Reports | 2013

Methylene blue reverses recalcitrant shock in β-blocker and calcium channel blocker overdose

Nidhi Aggarwal; Yizhak Kupfer; Chanaka Seneviratne; Sidney Tessler

β-blocker and calcium channel blocker toxicity generally present with bradycardia and hypotension. A 69-year-old woman presented after a suicide attempt with a β-blocker and calcium channel blocker overdose. Her blood pressure was 69/35 mm Hg and her HR was in the 40s. She was treated with calcium chloride, glucagon, a dextrose–insulin infusion and three vasopressors, but remained hypotensive. She suffered two cardiac arrests and required a transvenous pacemaker. When all interventions failed, she was started on a methylene blue infusion for refractory vasodilatory shock which resulted in a dramatic improvement in her blood pressure. The patient was successfully weaned off all vasopressors and from mechanical ventilation without any end-organ damage.


Case Reports | 2013

Severe epistaxis after nasogastric tube insertion requiring arterial embolisation

Vishesh Paul; Yizhak Kupfer; Sidney Tessler

A 53-year-old dialysis patient was admitted with symptoms of a respiratory tract infection, abdominal pain and vomiting. She aspirated and required intubation. A nasogastric tube was placed with slight difficulty and the patient developed severe epistaxis. The bleeding could not be controlled with mechanical pressure and nasal packing. Angiography revealed extravasation from a pseudoaneurysm arising from the inferior pharyngeal branch of the ascending pharyngeal trunk. The vessel was successfully embolised with cessation of bleeding. We emphasise that even a seemingly easy procedure like insertion of a nasogastric tube, can lead to a life-threatening complication.


The American Journal of the Medical Sciences | 2011

Prosthetic Valve Endocarditis Caused by Gemella sanguinis: A Consequence of Persistent Dental Infection

Prashant Gundre; William Pascal; Yizhak Kupfer; Sidney Tessler; Sunil Abrol

Late prosthetic valve endocarditis is usually caused by streptococci, staphylococci, gram-negative bacilli and candida. The authors report the first case of prosthetic valve endocarditis caused by Gemella sanguinis. The patients risk factors for the development of Gemella endocarditis were the persistent severe dental caries and the presence of prosthetic valves. The patient required surgical replacement of the infected valve but had a good outcome with preservation of cardiac and valvular function. Evaluation and treatment of the persistent dental infection before initial valvular surgery may have prevented secondary infection of the prosthetic valve.


Case Reports | 2013

Pulmonary artery catheter coiled in the main pulmonary artery trunk.

Nidhi Aggarwal; Yizhak Kupfer; Taek Yoon; Sidney Tessler

Pulmonary artery (PA) catheterisation has been performed for over four decades. It is utilised in intensive care units and perioperatively to titrate fluid and pressor therapy. Major and minor complications have been reported. The catheter can infrequently loop and coil in the right atrium, right ventricle and superior vena cava .We report a case of coiling of the PA catheter in the main PA. A 33-year-old woman was admitted with multiorgan failure and shock. She required mechanical ventilation, was in severe pulmonary oedema and required vasopressors for shock. We placed a PA catheter to assist in the management of her haemodynamic collapse. The catheter coiled in the main pulmonary trunk, which is extremely rare. The catheter was removed without any complications.

Collaboration


Dive into the Yizhak Kupfer's collaboration.

Top Co-Authors

Avatar

Sidney Tessler

Maimonides Medical Center

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Nidhi Aggarwal

Maimonides Medical Center

View shared research outputs
Top Co-Authors

Avatar

Taek Yoon

Maimonides Medical Center

View shared research outputs
Top Co-Authors

Avatar

Anand Kumar Rai

Maimonides Medical Center

View shared research outputs
Top Co-Authors

Avatar

Kabu Chawla

Maimonides Medical Center

View shared research outputs
Top Co-Authors

Avatar

Shyam Shankar

Maimonides Medical Center

View shared research outputs
Top Co-Authors

Avatar

William Pascal

Maimonides Medical Center

View shared research outputs
Top Co-Authors

Avatar

Pavan Irukulla

Maimonides Medical Center

View shared research outputs
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge